CSIMarket Company Name, Ticker, Industry, else..
 
Novan Inc   (NASDAQ: NOVN)
 

NOVN's Market share relative to its competitors, as of Q1 2023

As of Q1 2023 (Revenue in Millions of $)

Date modified: 2026-07-18T13:13:33+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2023		 MARKET SHARE
12 Months
Q1 2023		 MARKET SHARE
MRQ
Q1 2023		 MARKET SHARE
A Quarter Before
Q4 2022
Novan Inc 24.92 0.01% 0.00 % 0.01 %
Eli Lilly And Company 79,665.80 16.44% 13.47% 12.75%
Merck and Co Inc 66,569.00 13.74% 9.74% 10.49%
Pfizer Inc 63,315.00 13.07% 8.81% 9.30%
Abbvie Inc 62,819.00 12.97% 9.96% 9.66%
Astrazeneca Plc 54,073.00 11.16% 34.44% 34.81%
72 more competitors available

Sign in to see all competitors for Novan Inc .

Sign In Create Free Account



NOVN's Market share relative to its competitors, as of Q1 2023 within the Major Pharmaceutical Preparations Industry
As of Q1 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
12 Months Ending
Q4 2022		 MARKET SHARE
MRQ
Q1 2023		 MARKET SHARE

Q4 2022
Novan Inc 0.01% 0.01% 0.00 % 0.01 %
Eli Lilly And Company 18.37% 16.10% 14.43% 13.64%
Merck and Co Inc 15.35% 16.05% 10.43% 11.22%
Pfizer Inc 14.60% 15.45% 9.44% 9.95%
Abbvie Inc 14.48% 15.10% 10.67% 10.33%
Astrazeneca Plc 12.47% 11.31% 36.89% 37.24%
69 more companies available

Sign in to see all industry competitors for Novan Inc .

Sign In Create Free Account



NOVN's Market share relative to its competitors, as of Q1 2023 within the Healthcare Sector
As of Q1 2023



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2023		 MARKET SHARE
12 Months Ending
Q4 2022		 MARKET SHARE
MRQ
Q1 2023		 MARKET SHARE

Q4 2022
Novan Inc 0.01% 0.01% 0.00 % 0.01 %
Eli Lilly And Company 16.44% 14.70% 13.47% 12.75%
Merck and Co Inc 13.74% 14.66% 9.74% 10.49%
Pfizer Inc 13.07% 14.11% 8.81% 9.30%
Abbvie Inc 12.97% 13.79% 9.96% 9.66%
Astrazeneca Plc 11.16% 10.33% 34.44% 34.81%
72 more companies available

Sign in to see all sector competitors for Novan Inc .

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Novan Inc's market divisions, geographic dispersion, segments, products, and services, visit Novan Inc's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.